BioMarin Pharmaceutical (BMRN) Stock Price Today & Analysis
BMRN
Valuation
Market cap$10.49B
Price-to-sales ratio3.42
Price-to-book value1.75
Price-earnings ratio20.30
Return on Equity9.00%
Return on Sales0.22%
Return on Assets0.07%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$2.72
Income Statement
Average volume2,952,343
EBITDA$772.70M
1 year high (52w)$73.51
1 year low (52w)$50.76
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About BioMarin Pharmaceutical
BioMarin is a world leader in developing and commercializing therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and life-threatening conditions where we can significantly improve upon the current standard of care.
FAQ
You can easily purchase BioMarin Pharmaceutical (BMRN) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'BMRN' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in BioMarin Pharmaceutical with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
